BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh S, Kullo IJ, Pardi DS, Loftus EV. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:26-35. [PMID: 25446727 DOI: 10.1038/nrgastro.2014.202] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Papada E, Forbes A, Amerikanou C, Torović L, Kalogeropoulos N, Tzavara C, Triantafillidis JK, Kaliora AC. Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. Nutrients 2018;10:E1779. [PMID: 30453494 DOI: 10.3390/nu10111779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
2 Üstün Y, Kilincalp S, Çoban Ş, Coşkun Y, Yüksel İ, Ongun A, Soykan İ, Bektaş M, Törüner M, Çetinkaya H, Örmeci N. Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease. Med Sci Monit 2016;22:3943-50. [PMID: 27773920 DOI: 10.12659/msm.898160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Voutilainen M, Hutri-kähönen N, Tossavainen P, Sipponen T, Pitkänen N, Laitinen T, Jokinen E, Rönnemaa T, Viikari JS, Raitakari OT, Juonala M. Low childhood high density lipoprotein cholesterol levels and subsequent risk for chronic inflammatory bowel disease. Digestive and Liver Disease 2018;50:348-52. [DOI: 10.1016/j.dld.2018.01.121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Vennou KE, Piovani D, Kontou PI, Bonovas S, Bagos PG. Multiple outcome meta-analysis of gene-expression data in inflammatory bowel disease. Genomics 2020;112:1761-7. [DOI: 10.1016/j.ygeno.2019.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Cainzos-Achirica M, Glassner K, Zawahir HS, Dey AK, Agrawal T, Quigley EMM, Abraham BP, Acquah I, Yahya T, Mehta NN, Nasir K. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:2895-905. [PMID: 33303079 DOI: 10.1016/j.jacc.2020.10.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Feng Y, He X, Luo S, Chen X, Long S, Liang F, Shi T, Pei Z, Li Z. Chronic colitis induces meninges traffic of gut-derived T cells, unbalances M1 and M2 microglia/macrophage and increases ischemic brain injury in mice. Brain Res 2019;1707:8-17. [PMID: 30445026 DOI: 10.1016/j.brainres.2018.11.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
7 Feng W, Chen G, Cai D, Zhao S, Cheng J, Shen H. Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta-Analysis of Cohort Studies. J Am Heart Assoc 2017;6:e005892. [PMID: 28768646 DOI: 10.1161/JAHA.117.005892] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
8 Wang H, Liu Z, Shao J, Lin L, Jiang M, Wang L, Lu X, Zhang H, Chen Y, Zhang R. Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications. J Immunol Res 2020;2020:4904217. [PMID: 32908939 DOI: 10.1155/2020/4904217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
9 Mironova OI, Isaikina MA, Khasieva SA. Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease. Terapevticheskii arkhiv 2022;93:1533-8. [DOI: 10.26442/00403660.2021.12.201225] [Reference Citation Analysis]
10 Rodríguez-Carrio J, Mozo L, López P, Nikiphorou E, Suárez A. Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases. Front Med (Lausanne) 2018;5:114. [PMID: 29740582 DOI: 10.3389/fmed.2018.00114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Xie W, Xiao S, Huang Y, Sun X, Zhang Z. Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials. Ther Adv Musculoskelet Dis 2019;11:1759720X19895492. [PMID: 31897092 DOI: 10.1177/1759720X19895492] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
12 Chen C, Li S, Liu K, Ma G, Yan X. Co-Assembly of Heparin and Polypeptide Hybrid Nanoparticles for Biomimetic Delivery and Anti-Thrombus Therapy. Small 2016;12:4719-25. [DOI: 10.1002/smll.201600328] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
13 Viscido A, Capannolo A, Petroni R, Stefanelli G, Zerboni G, De Martinis M, Necozione S, Penco M, Frieri G, Latella G, Romano S. Association between Corrected QT Interval and C-Reactive Protein in Patients with Inflammatory Bowel Diseases. Medicina (Kaunas) 2020;56:E382. [PMID: 32751480 DOI: 10.3390/medicina56080382] [Reference Citation Analysis]
14 Murphy K, Waldo O, Lohrmann GM, Tazelaar HD, Jokerst CE, Mookadam F. Eosinophilia and Ulcerative Colitis Associated with Eosinophilic Myocarditis. Tex Heart Inst J 2017;44:219-22. [PMID: 28761405 DOI: 10.14503/THIJ-16-5859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Jin G, Tang Q, Ma J, Liu X, Zhou B, Sun Y, Pang X, Guo Z, Xie R, Liu T, Wang B, Cao H. Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood. mSystems 2021;6:e01337-20. [PMID: 33727402 DOI: 10.1128/mSystems.01337-20] [Reference Citation Analysis]
16 Amini-Khoei H, Momeny M, Abdollahi A, Dehpour AR, Amiri S, Haj-Mirzaian A, Tavangar SM, Ghaffari SH, Rahimian R, Mehr SE. Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage. Int Immunopharmacol. 2016;36:9-16. [PMID: 27104313 DOI: 10.1016/j.intimp.2016.04.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
17 Tang GY, Meng X, Li Y, Zhao CN, Liu Q, Li HB. Effects of Vegetables on Cardiovascular Diseases and Related Mechanisms. Nutrients. 2017;9. [PMID: 28796173 DOI: 10.3390/nu9080857] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 12.2] [Reference Citation Analysis]
18 Solitano V, Fiorino G, D'Amico F, Peyrin-Biroulet L, Danese S. Thrombosis in IBD in the Era of JAK Inhibition. Curr Drug Targets 2021;22:126-36. [PMID: 32881668 DOI: 10.2174/1389450121666200902164240] [Reference Citation Analysis]
19 Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, Sita G, Racchumi G, Ling L, Pamer EG, Iadecola C, Anrather J. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat Med 2016;22:516-23. [PMID: 27019327 DOI: 10.1038/nm.4068] [Cited by in Crossref: 354] [Cited by in F6Publishing: 350] [Article Influence: 59.0] [Reference Citation Analysis]
20 Mancini S, Mariani F, Sena P, Benincasa M, Roncucci L. Myeloperoxidase expression in human colonic mucosa is related to systemic oxidative balance in healthy subjects. Redox Rep 2017;22:399-407. [PMID: 28064732 DOI: 10.1080/13510002.2016.1277049] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
21 Aguiar LM, Bicas JL, Fuentes E, Alarcón M, Gonzalez IP, Pastore GM, Maróstica MR Junior, Cazarin CBB. Non-nutrients and nutrients from Latin American fruits for the prevention of cardiovascular diseases. Food Res Int 2021;139:109844. [PMID: 33509467 DOI: 10.1016/j.foodres.2020.109844] [Reference Citation Analysis]
22 Mazaheri M, Karimian M, Behjati M, Raygan F, Hosseinzadeh Colagar A. Association analysis of rs1049255 and rs4673 transitions in p22phox gene with coronary artery disease: A case-control study and a computational analysis. Ir J Med Sci 2017;186:921-8. [PMID: 28474233 DOI: 10.1007/s11845-017-1601-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
23 Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, Khan NS, Wong CK, Shamailova R, Hill CA, Wang Z, Remark R, Li JR, Pina C, Faries C, Awad AJ, Moss N, Bjorkegren JLM, Kim-Schulze S, Gnjatic S, Ma'ayan A, Mocco J, Faries P, Merad M, Giannarelli C. Single-cell immune landscape of human atherosclerotic plaques. Nat Med 2019;25:1576-88. [PMID: 31591603 DOI: 10.1038/s41591-019-0590-4] [Cited by in Crossref: 160] [Cited by in F6Publishing: 144] [Article Influence: 53.3] [Reference Citation Analysis]
24 Wu P, Jia F, Zhang B, Zhang P. Risk of cardiovascular disease in inflammatory bowel disease. Exp Ther Med 2017;13:395-400. [PMID: 28352306 DOI: 10.3892/etm.2016.3966] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
25 Koutroumpakis E, Ramos-Rivers C, Regueiro M, Hashash JG, Barrie A, Swoger J, Baidoo L, Schwartz M, Dunn MA, Koutroubakis IE, Binion DG. Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016;61:865-71. [PMID: 26514677 DOI: 10.1007/s10620-015-3932-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
26 Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?Trends Cardiovasc Med. 2020;30:463-469. [PMID: 31653485 DOI: 10.1016/j.tcm.2019.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
27 Biondi RB, Salmazo PS, Bazan SGZ, Hueb JC, de Paiva SAR, Sassaki LY. Cardiovascular Risk in Individuals with Inflammatory Bowel Disease. Clin Exp Gastroenterol 2020;13:107-13. [PMID: 32425576 DOI: 10.2147/CEG.S243478] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Lu L, Zhang J, Xie Y, Gao F, Xu S, Wu X, Ye Z. Wearable Health Devices in Health Care: Narrative Systematic Review. JMIR Mhealth Uhealth 2020;8:e18907. [PMID: 33164904 DOI: 10.2196/18907] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
29 Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453143 DOI: 10.1038/s41575-021-00492-8] [Reference Citation Analysis]
30 Nguyen NH, Ohno-Machado L, Sandborn WJ, Singh S. Infections and Cardiovascular Complications are Common Causes for Hospitalization in Older Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018;24:916-23. [PMID: 29562273 DOI: 10.1093/ibd/izx089] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
31 Xu H, Li H, Zhu P, Liu Y, Zhou M, Chen A. Tanshinone IIA Ameliorates Progression of CAD Through Regulating Cardiac H9c2 Cells Proliferation and Apoptosis by miR-133a-3p/EGFR Axis. Drug Des Devel Ther 2020;14:2853-63. [PMID: 32764884 DOI: 10.2147/DDDT.S245970] [Reference Citation Analysis]
32 Maev IV, Kazulin AN, Andreev DN. The cardiovascular system in patients with functional and inflammatory bowel diseases. Ter Arkh 2018;90:59-64. [PMID: 30701774 DOI: 10.26442/terarkh201890259-64] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Koutroubakis IE. The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implications. Expert Rev Clin Immunol. 2015;11:479-488. [PMID: 25719625 DOI: 10.1586/1744666x.2015.1019475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Persaud A, Ahmed A, Kakked G, Shulik O, Ahlawat S. Association of Autoimmune Hepatitis and Cardiovascular Disease. Digestive and Liver Disease 2019;51:1604-9. [DOI: 10.1016/j.dld.2019.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
35 Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7625-7644 [PMID: 27678347 DOI: 10.3748/wjg.v22.i34.7625] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
36 Alicic D, Martinovic D, Rusic D, Zivkovic PM, Tadin Hadjina I, Vilovic M, Kumric M, Tokic D, Supe-Domic D, Lupi-Ferandin S, Bozic J. Urotensin II levels in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(36): 6142-6153 [PMID: 34629825 DOI: 10.3748/wjg.v27.i36.6142] [Reference Citation Analysis]
37 Chen Y, Wang X. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis. Brain Behav 2021;11:e02159. [PMID: 33960728 DOI: 10.1002/brb3.2159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Bjerrum JT, Steenholdt C, Ainsworth M, Nielsen OH, Reed MA, Atkins K, Günther UL, Hao F, Wang Y. Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease. BMC Med 2017;15:184. [PMID: 29032767 DOI: 10.1186/s12916-017-0949-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
39 Choi YJ, Lee DH, Shin DW, Han K, Yoon H, Shin CM, Park YS, Kim N. Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study. Aliment Pharmacol Ther 2019;50:769-79. [DOI: 10.1111/apt.15446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
40 Di Sabatino A, Santilli F, Guerci M, Simeone P, Ardizzone S, Massari A, Giuffrida P, Tripaldi R, Malara A, Liani R, Gurini E, Aronico N, Balduini A, Corazza GR, Davì G. Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment. Thromb Haemost 2016;116:486-95. [PMID: 27305860 DOI: 10.1160/TH16-02-0167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
41 Rungoe C, Nyboe Andersen N, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med. 2015;25:699-704. [PMID: 25912602 DOI: 10.1016/j.tcm.2015.03.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
42 Kondubhatla K, Kaushal A, Daoud A, Shabbir H, Mostafa JA. Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma. Cureus 2020;12:e10544. [PMID: 33062549 DOI: 10.7759/cureus.10544] [Reference Citation Analysis]
43 Zanoli L, Mikhailidis DP, Bruno RM, Abreu MT, Danese S, Eliakim R, Gionchetti P, Katsanos KH, Kirchgesner J, Koutroubakis IE, Kucharzik T, Lakatos PL, Nguyen GC, Papa A, Vavricka SR, Wilkinson IB, Boutouyrie P. Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement. Angiology 2020;71:689-97. [DOI: 10.1177/0003319720918509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
44 Song T, Yao Y, Wang T, Huang H, Xia H. Tanshinone IIA ameliorates apoptosis of myocardiocytes by up-regulation of miR-133 and suppression of Caspase-9. Eur J Pharmacol 2017;815:343-50. [PMID: 28867607 DOI: 10.1016/j.ejphar.2017.08.041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
45 Patoulias DI. Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden. Arch Med Sci Atheroscler Dis 2019;4:e250-1. [PMID: 32368680 DOI: 10.5114/amsad.2019.90147] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Taleban S. Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly. Curr Treat Options Gastro 2015;13:275-86. [DOI: 10.1007/s11938-015-0059-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
47 Yuan F, Zhang YH, Kong XY, Cai YD. Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach. Biomed Res Int. 2017;2017:5741948. [PMID: 28293637 DOI: 10.1155/2017/5741948] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
48 Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol 2017; 23(7): 1241-1249 [PMID: 28275304 DOI: 10.3748/wjg.v23.i7.1241] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
49 Łykowska-Szuber L, Rychter AM, Dudek M, Ratajczak AE, Szymczak-Tomczak A, Zawada A, Eder P, Lesiak M, Dobrowolska A, Krela-Kaźmierczak I. What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review. Nutrients 2021;13:2661. [PMID: 34444821 DOI: 10.3390/nu13082661] [Reference Citation Analysis]
50 Dregan A, Chowienczyk P, Molokhia M. Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders. Heart 2017;103:1867-73. [PMID: 28601812 DOI: 10.1136/heartjnl-2017-311214] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
51 Barroso T, Conway F, Emel S, McMillan D, Young D, Karteszi H, Gaya DR, Gerasimidis K. Patients with inflammatory bowel disease have higher abdominal adiposity and less skeletal mass than healthy controls.Ann Gastroenterol. 2018;31:566-571. [PMID: 30174393 DOI: 10.20524/aog.2018.0280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
52 Romero-Castro A, Gutiérrez-Sánchez M, Correa-Basurto J, Rosales Hernández MC, Padilla Martínez II, Mendieta-Wejebe JE. Pharmacokinetics in Wistar Rats of 5-[(4-Carboxybutanoyl)Amino]-2-Hydroxybenzoic Acid: A Novel Synthetic Derivative of 5-Aminosalicylic Acid (5-ASA) with Possible Anti-Inflammatory Activity. PLoS One 2016;11:e0159889. [PMID: 27454774 DOI: 10.1371/journal.pone.0159889] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Hensel KO, Abellan Schneyder FE, Wilke L, Heusch A, Wirth S, Jenke AC. Speckle Tracking Stress Echocardiography Uncovers Early Subclinical Cardiac Involvement in Pediatric Patients with Inflammatory Bowel Diseases. Sci Rep 2017;7:2966. [PMID: 28592829 DOI: 10.1038/s41598-017-03255-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
54 Wang D, Zhang Y, Yang S, Zhao D, Wang M. A polysaccharide from cultured mycelium of Hericium erinaceus relieves ulcerative colitis by counteracting oxidative stress and improving mitochondrial function. Int J Biol Macromol 2019;125:572-9. [PMID: 30543884 DOI: 10.1016/j.ijbiomac.2018.12.092] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
55 Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M; BERENICE study group. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut. 2018;67:1261-1268. [PMID: 28647686 DOI: 10.1136/gutjnl-2017-314015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]